Patients with Alzheimer’s disease experienced rapid and significant improvements in agitation with a combination of CBD and ...
Results presented by the LiBBY study team at the Alzheimer’s Association International Conference (“AAIC”) demonstrated statistically significant improvements in agitation symptoms compared with ...
Leiutis Pharma gets CDSCO nod for global-first synthetic CBD therapy for mild to moderate anxiety disorders: Our Bureau, Bengaluru Tuesday, July 14, 2026, 16:25 Hrs [IST] Leiutis ...
Some athletes are turning to cannabis to lock into long runs, push past pain, and float across finish lines. Are they onto ...
9hon MSN
Cannabis-derived treatment eases agitation in hospice-eligible dementia patients, trial finds
In a first-of-its-kind clinical trial, U.S. researchers found that people with agitation and dementia in late life who took a ...
Health and Me on MSN
India approves world's first synthetic CBD therapy for anxiety disorders
Leiutis Pharmaceuticals' newly approved medicine contains a fully synthetic cannabidiol (CBD) active pharmaceutical ...
Medications such as morphine, Valium and Haldol have been found to have limited effectiveness in treating dementia-related ...
A new meta-analysis suggests that CBD may improve emotional behavior and cognition in animal models, but researchers caution ...
PsyPost on MSN
Cannabidiol shows no significant benefit for treating psychotic disorders, new study finds
Recent research published in the Journal of Psychopharmacology suggests that cannabidiol, a non-intoxicating compound found ...
A new study has found cannabidiol (medicinal cannabis) to be a promising treatment for several drug-resistant forms of ...
CANNABIS might help to calm dementia patients by reducing agitation, according to a study. People with the disease often ...
Former acting DHS Secretary Chad Wolf urges Congress to investigate Chinese-linked actors' role in THC hemp products and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results